AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
- Summit: 4 events in the last 90 days
- Previous: 9 days earlier · NWSL Power Rankings: Denver Summit and Angel City most in form at the moment, while contenders slip
What happened
Pascal Soriot spoke exclusively with CNBC from the site of AstraZeneca's new $1 billion R&D facility in Kendall Square in Cambridge, Massachusetts.
Summary assembled by rule from the sources below